CD8A and neoplasm: However, p-p65, MHC-I and tumor-infiltrating CD8+ cytotoxic T cells were significantly elevated in Pd-l1-deficient CT26 tumor tissues treated with the USP8 inhibitor alone or combination compared with the control group (Supplementary Fig. 7n–r).